1/25/2022 | 2933998008 | IRBESARTAN , WORKING STANDARD NON-DRUG, POWDER, REFERENCE SAMPLE, FOR EXAMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS, FOR LABORATORS. STUDIES WILL NOT BE USED FOR PREVENTION, DIAGNOSIS, TREATMENT | 0 | 511.12 | France | MOSCOW RUSSIA | CLOSED JSC KANONFARMA PRODUCTION |
1/25/2022 | 2933998008 | IRBESARTAN IMPURITY A , WORKING STANDARD NON-DRUG, POWDER, REFERENCE SAMPLE, FOR EXAMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS, FOR LABORATORY. STUDIES WILL NOT BE USED FOR PREVENTION, DIAGNOSIS, | 0 | 2401.12 | France | MOSCOW RUSSIA | CLOSED JSC KANONFARMA PRODUCTION |
1/14/2022 | 2933998008 | Benzydamine impurity A (BP) IN THE FORM OF HYDROCHLORIDE [3-DIMETHYLAMINOPROPYL 2-BENZYLAMINOBENZOATE HYDROCHLORIDE] - SAMPLE OF REFERENCE STANDARD SUBSTANCE FOR QUALITY CONTROL OF MEDICINES. FUNDS IN THE PHARM LABORATORY. PLANT LLC KRKA-RUS (ISTRA). NOT | 0.02 | 128.53 | United Kingdom | ISTRA | KRKA RUS LLC |
1/26/2022 | 2933998008 | HETEROCYCLIC COMPOUNDS CONTAINING ONLY NITROGEN HETEROATOM(S): THE REFERENCE STANDARD OF THE SUBSTANCE VILDAGLIPTIN. CHEMICAL NAME: (S)-1-[2-(3-HYDROXYADAMANTANE-1-YLAMINO)ACETYL]PIRROLIDINE-2-CARBONITRILLE. EMPIRICAL FORMULA: C17H25N30 | 0.01 | 47.97 | Switzerland | ST PETERSBURG RUSSIA | NOVARTIS NEVA LLC |
1/28/2022 | 2933599500 | WORKING STANDARD, NOT A DRUG: REFERENCE SAMPLE, FOR EXAMINATION, FOR LABORATORY STUDIES. WILL NOT BE USED FOR THE PREVENTION, DIAGNOSTICS, TREATMENT OF DISEASES, NOT INTENDED FOR THE MANUFACTURE OF MEDICINES | 0 | 4461.81 | India | MOSCOW RUSSIA | NEW LAB LLC |
1/28/2022 | 2933998008 | WORKING STANDARD, NOT A DRUG: REFERENCE SAMPLE, FOR EXAMINATION, FOR LABORATORY STUDIES. WILL NOT BE USED FOR THE PREVENTION, DIAGNOSTICS, TREATMENT OF DISEASES, NOT INTENDED FOR THE MANUFACTURE OF MEDICINES | 0 | 508.94 | Ireland | MOSCOW RUSSIA | NEW LAB LLC |
1/25/2022 | 2933599500 | HYDROXYZINE IMPURITY A , WORKING STANDARD NON-DRUG, POWDER, REFERENCE SAMPLE, FOR EXAMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS, FOR LABORATORS. STUDIES WILL NOT BE USED FOR PREVENTION, DIAGNOSIS, | 0 | 2587.12 | Canada | MOSCOW RUSSIA | CLOSED JSC KANONFARMA PRODUCTION |
1/25/2022 | 2933299000 | LOZARTAN POTASSIUM , WORKING STANDARD NON-DRUG, POWDER, REFERENCE SAMPLE, FOR EXAMINATION OF ACTIVE PHARMACEUTICAL INGREDIENTS, FOR LABORATOR. STUDIES WILL NOT BE USED FOR PREVENTION, DIAGNOSIS, TREATMENT | 0 | 511.12 | France | MOSCOW RUSSIA | CLOSED JSC KANONFARMA PRODUCTION |
1/26/2022 | 2933998008 | HETEROCYCLIC COMPOUNDS CONTAINING ONLY NITROGEN HETEROATOM(S): A REFERENCE STANDARD OF THE SUBSTANCE SACUBITRYL VALSARTAN. CHEMICAL NAME: 3-{[2S,4R)-1-{[1,1'-BIPHENYL]-4-YL)-4-METHYL-5-OXO-5-ETOXYPEPTAN-2-YL]K ARBOMYL}PROPANOIC ACID | 0.01 | 240.42 | United Kingdom | ST PETERSBURG RUSSIA | NOVARTIS NEVA LLC |
1/28/2022 | 2933790000 | WORKING STANDARD, NOT A DRUG: REFERENCE SAMPLE, FOR EXAMINATION, FOR LABORATORY STUDIES. WILL NOT BE USED FOR THE PREVENTION, DIAGNOSTICS, TREATMENT OF DISEASES, NOT INTENDED FOR THE MANUFACTURE OF MEDICINES | 0 | 891.17 | Singapore | MOSCOW RUSSIA | NEW LAB LLC |